Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon
A new psychedelic treatment called luvesilocin is showing promise in clinical trials for treating postpartum depression and anxiety. Researchers believe this drug could offer rapid relief for conditions that currently affect nearly 20% of new mothers.
Why it matters
Postpartum mental health issues carry significant risks for both mother and infant, making new, effective treatment options a critical public health priority.
Women with postpartum depression and anxiety have a higher risk of birth complications and death by suicide. Justin Paget/DigitalVision via Getty Images Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon Published: July 7, 2026 8:15am EDT https://theconversation.com/nearly-20-of-new-moms-have-anxiety-or-depression-but-a-promising-psychedelic-treatment-is-on-the-horizon-283028 https://theconversation.com/nearly-20-of-new-moms-have-anxiety-or-depression-but-a-promising-psychedelic-treatment-is-on-the-horizon-283028 Link copied Share article Share article
The article reports on clinical trial findings and medical research without taking a political stance or using loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in